City Therapeutics, Inc (CTY) insider trading
Every open-market stock purchase and sale by City Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Robert Nelsen (10% owner) bought $3.1M in the last 90 days.
Last 12 months: insiders bought $3.1M (1 buy) and sold $0 (0 sales). Last close $20.43 on Oct 21, 2026.
Recent CTY insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 19, 2026 | Robert Nelsen (10% owner) | Bought | $3.1M |
| Oct 19, 2026 | ARCH Venture Partners XII LLC (10% owner) | Bought (not open market) | $3.1M |
| Oct 19, 2026 | ARCH Venture Partners XII LLC (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | ARCH Venture Partners XII LLC (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | ARCH Venture Partners XII LLC (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | ARCH Venture Partners XII LLC (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | ARCH Venture Partners XII LLC (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | John Maraganore (Director) | Bought (not open market) | — |
| Oct 19, 2026 | John Maraganore (Director) | Bought (not open market) | — |
| Oct 19, 2026 | John Maraganore (Director) | Bought (not open market) | — |
| Oct 19, 2026 | Andrew C. Orth (CEO) | Bought (not open market) | — |
| Oct 19, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
| Oct 19, 2026 | ARCH Venture Partners XII LLC (10% owner) | Bought (not open market) | — |
| Oct 15, 2026 | John Maraganore (Director) | Bought (not open market) | — |
| Oct 15, 2026 | Sara Nochur (Director) | Bought (not open market) | — |
| Oct 15, 2026 | Ron M Philip (Director) | Bought (not open market) | — |
| Oct 15, 2026 | Barry E Greene (Director) | Bought (not open market) | — |
| Oct 15, 2026 | Robert Nelsen (10% owner) | Bought (not open market) | — |
Who's trading CTY
- Robert Nelsen, 10% owner: bought $3.1M (1 buy), last Oct 19, 2026
- John Maraganore, Director: other filings, last Oct 19, 2026
- ARCH Venture Partners XII LLC, 10% owner: other filings, last Oct 19, 2026
- Andrew C. Orth, CEO: other filings, last Oct 19, 2026
- Barry E Greene, Director: other filings, last Oct 15, 2026
- Sara Nochur, Director: other filings, last Oct 15, 2026
- Ron M Philip, Director: other filings, last Oct 15, 2026
Get free alerts when an insider at City Therapeutics, Inc files a new trade →